Correlation Between Phio Pharmaceuticals and InMed Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Phio Pharmaceuticals and InMed Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Phio Pharmaceuticals and InMed Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Phio Pharmaceuticals Corp and InMed Pharmaceuticals, you can compare the effects of market volatilities on Phio Pharmaceuticals and InMed Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Phio Pharmaceuticals with a short position of InMed Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Phio Pharmaceuticals and InMed Pharmaceuticals.
Diversification Opportunities for Phio Pharmaceuticals and InMed Pharmaceuticals
0.26 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Phio and InMed is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Phio Pharmaceuticals Corp and InMed Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on InMed Pharmaceuticals and Phio Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Phio Pharmaceuticals Corp are associated (or correlated) with InMed Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of InMed Pharmaceuticals has no effect on the direction of Phio Pharmaceuticals i.e., Phio Pharmaceuticals and InMed Pharmaceuticals go up and down completely randomly.
Pair Corralation between Phio Pharmaceuticals and InMed Pharmaceuticals
Given the investment horizon of 90 days Phio Pharmaceuticals Corp is expected to under-perform the InMed Pharmaceuticals. In addition to that, Phio Pharmaceuticals is 1.23 times more volatile than InMed Pharmaceuticals. It trades about -0.15 of its total potential returns per unit of risk. InMed Pharmaceuticals is currently generating about -0.01 per unit of volatility. If you would invest 466.00 in InMed Pharmaceuticals on September 23, 2024 and sell it today you would lose (26.00) from holding InMed Pharmaceuticals or give up 5.58% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Phio Pharmaceuticals Corp vs. InMed Pharmaceuticals
Performance |
Timeline |
Phio Pharmaceuticals Corp |
InMed Pharmaceuticals |
Phio Pharmaceuticals and InMed Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Phio Pharmaceuticals and InMed Pharmaceuticals
The main advantage of trading using opposite Phio Pharmaceuticals and InMed Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Phio Pharmaceuticals position performs unexpectedly, InMed Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in InMed Pharmaceuticals will offset losses from the drop in InMed Pharmaceuticals' long position.Phio Pharmaceuticals vs. Zura Bio Limited | Phio Pharmaceuticals vs. Immix Biopharma | Phio Pharmaceuticals vs. Cns Pharmaceuticals | Phio Pharmaceuticals vs. ZyVersa Therapeutics |
InMed Pharmaceuticals vs. Fate Therapeutics | InMed Pharmaceuticals vs. Sana Biotechnology | InMed Pharmaceuticals vs. Caribou Biosciences | InMed Pharmaceuticals vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Stocks Directory Find actively traded stocks across global markets | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |